The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?
Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...
GSK launches $2.5 billion buyback, lifts sales target after stellar Q4
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
Investomania16h
FTSE 100 climbs as BoE rate decision looms amid inflation concerns
FTSE Climbs on rate cut hopes amid inflation heat; GSK Soars 7.6%. US trade gap widens.
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
These S&P 500 Stocks Yield 6%. They Could Be Better Than Bonds.
Investors are supposed to rely on bonds for stability and income. Fortunately, there are plenty of blue-chip stocks with yields that beat what investors can earn from broad-based bond funds. To sort ...
US imports hit record high as Trump tariffs backfire
US imports surged to a record high in December, official figures showed today as Donald Trump’s threat of tariffs triggered a rush among American companies to import goods.
London close: Stocks rise as trade tensions continue
London stocks edged higher on Wednesday as investors weighed the ongoing effects of trade tensions linked to US president ...